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Structure of the Rab7:REP-1 Complex:
Insights into the Mechanism of Rab Prenylation
and Choroideremia Disease
target membranes. REP molecules preferentially recruit
the GDP form of newly synthesized Rab proteins and
present them to the Rab geranylgeranyl transferase
(RabGGTase), which transfers one or two geranylgeranyl
moieties to the C-terminal cysteines (Andres et al., 1993).
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44227 Dortmund After prenylation, REP chaperones the Rab protein to
its target membrane, where it is converted into its activeGermany
2 Division of Biology GTP bound form. RabGTPase is converted back into
the inactive GDP bound form upon completion of itsCalifornia Institute of Technology
Pasadena, California 91125 functional cycle and can then be recognized by RabGDI,
a molecule that displays several stretches of high se-
quence conservation to REP molecules.
The structure of REP-1 was solved previously in com-Summary
plex with RabGGTase and revealed a two domain mole-
cule very similar to RabGDI (Pylypenko et al., 2003).Members of the RabGDI/REP family serve as multi-
functional regulators of the Rab family of GTP binding Several functional elements such as the Rab binding
platform (RBP) and the mobile effector loop (MEL) areproteins. Mutations in members of this family, such
as REP-1, lead to abnormalities, including progressive highly conserved between both molecules (Schalk et
al., 1996). REP-1, however, displayed several uniqueretinal degradation (choroideremia) in humans. The
crystal structures of the REP-1 protein in complex with features such as, for example, a RabGGTase binding
site located at the bottom of domain II. The recentlymonoprenylated or C-terminally truncated Rab7 pro-
teins revealed that Rab7 interacts with the Rab binding published structure of prenylated Ypt1:GDI complex
confirmed that the RBP is a Rab binding site and re-platform of REP-1 via an extended interface involving
the Switch 1 and 2 regions. The C terminus of the vealed an additional C terminus binding region (CBR)
that coordinates the C terminus of Ypt1 and directs itREP-1 molecule functions as a mobile lid covering a
conserved hydrophobic patch on the surface of REP-1 toward a lipid binding site located on domain II (Rak et
al., 2003a).that in the complex coordinates the C terminus of Rab
proteins. Using semisynthetic fluorescent Rab27A, we Considering the number of intracellular processes
controlled by RabGTPases, it is not surprising that de-demonstrate that although Rab27A can be prenylated
by REP-2, this reaction can be effectively inhibited fects in their prenylation lead to abnormalities in mam-
mals. Mutations in the RabGGTase and REP-1 genesby other Rab proteins, providing a possible explana-
tion for the accumulation of unprenylated Rab27A in lead to diseases known as Hermansky-Pudlak syn-
drome and choroideremia (CHM), respectively (Seabrachoroideremia.
et al., 2002). In both cases, cells accumulate unprenyl-
ated Rab proteins, but in the case of choroideremia,Introduction
underprenylation appears to specifically affect Rab27A.
The disease manifests as X chromosome-linked chorio-Posttranslational modification of proteins with geranyl-
geranyl or farnesyl moieties covalently attached to retinal degeneration leading to complete blindness
(Cremers et al., 1994). It was proposed to be a conse-C-terminal cysteine(s) of the protein represents a wide-
spread phenomenon affecting up to 2% of eukaryotic quence of low affinity of REP-2 for Rab27A or alterna-
tively a result of low affinity of RabGGTase for theproteins (Gelb, 1997). The majority of molecules that
acquire these modifications belong to the superfamily Rab27A:REP-2 complex (Larijani et al., 2003; Seabra,
1996).of Ras-like GTPases. The presence of the isoprenoid
group enables the GTPases to associate reversibly with Here, we report the structures of the REP-1 in com-
plex with monoprenylated and C terminally truncatedintracellular membranes, which is critical for their biolog-
ical activity. With more than 60 members, Rab GTPases Rab7:GDP. Moreover, we present structures of apo-
Rab7 in the GDP- and GppNHp bound states that provideconstitute the most prominent branch of the Ras super-
family of GTPases and are involved in a broad spectrum detailed information on the nature of nucleotide-depen-
dent interaction of RabGTPases with REP proteins.of intracellular trafficking events such as vesicle bud-
ding, targeting, fusion, and motility (Segev, 2001). De-
spite the large number of RabGTPases, two types of Results and Discussion
interacting molecules are shared by all known Rab pro-
teins: the Rab escort protein (REP) and Rab GDP-disso- Structure Determination of Rab7:REP-1
ciation inhibitor (RabGDI) (Alory and Balch, 2001). These Complexes, apo-Rab7:GDP
molecules form a family of RabGDI/REP proteins that and apo-Rab7:GppNHp
mediate the posttranslational prenylation of Rab pro- A C-terminal mutant (C205S) of Rab7 containing only
teins and modulate their subsequent interaction with one prenylatable cysteine was complexed to REP-1,
prenylated in vitro using immobilized RabGGTase, and
crystallized as described elsewhere (Rak et al., 2003b).*Correspondence: kirill.alexandrov@mpi-dortmund.mpg.de
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The crystal structure of the prenylated Rab7GG:REP-1 brane, the loss of affinity is likely to pose an insurmount-
able obstacle.complex was solved to 2.2 A˚ resolution by molecular
replacement method with REP-1 as a search model (see Additional mutations of the conserved Switch II region
residues corresponding to positions RabL73, RabY78, andExperimental Procedures). Rab7 C-terminally truncated
by 22 amino acid was complexed with REP-1, crystal- RabA81 were shown to perturb the interaction of Rab1B
with REP-1 (Overmeyer et al., 1998). Interestingly, nonelized and the structure was determined to 2.5 A˚ resolu-
tion by molecular replacement using the prenylated of these mutations is actually involved in formation of
the binding interface with REP-1. Instead, they pointRab7:REP-1 complex as a search model. Rab7:GDP and
Rab7:GppNHp proteins were crystallized as described toward the core of the Rab7 molecule and stabilize the
structure of Switch II. It appears that collapse of thein the Experimental Procedures section and their struc-
tures were solved using the model of Rab7 from the hydrophobic scaffold of Switch II is more detrimental
for integrity the Rab:REP interface than the loss of theRab7:REP-1 complex to 1.9 and 1.7 A˚ resolution, re-
spectively. Data collection and refinement statistics for individual contacts.
Comparison of the Rab7:REP-1 interface with the in-all four structures are summarized in Table 1.
terface of the recently solved Ypt1:GDI complex reveals
a remarkable structural similarity of both complexesStructure of the Rab7:REP-1 Interface
(Figures 1B, 2, and Supplemental Figure S3 available onThe structure of prenylated Rab7 in complex with REP-1
Cell website) (Rak et al., 2003a). Out of 32 residues ofexhibits a typical G-domain globular fold with an ex-
REP-1 involved in formation of the complex interface,tended C terminus. The last 11 amino acids of Rab7
15 residues are invariant between RabGDI and REP, 11are not visible in the electron density map and most
residues are conserved, and 6 residues appear to beprobably do not have a defined position. Similar to the
unique for the Rab:REP interaction (Figures 1 and 2). Ofprenylated Ypt1 in complex with RabGDI, the prenylated
the latter group, residues repA252, repS249 and repL374Rab contacts REP-1 domain I via two binding sites: the
are located in the CBR and RBP and are involved inRab7 globular part is bound to the Rab binding platform
coordination of the C terminus. Residues repR223 and(RBP) of REP-1 while the visible part of Rab7’s extended
repR398 are located at the link between  helix B and theC terminus is coordinated by the C terminus binding
RBP, forming interactions with the 3-loop7 and Switchregion (CBR) of REP-1. The C-terminal Rab7 prenyl
II of Rab7, respectively. Residue repR398 of the RBPgroup is harbored by REP-1 domain II (Figure 1A). In the
forms two strong hydrogen bonds with the main chainstructure of the Rab7C22:REP-1 complex, the GTPase
oxygen of rabQ71 and is conserved in REP but not ininteracts only with the Rab binding platform of REP-1,
RabGDI proteins. Analysis of the distribution of invariant,indicating that the interaction with CBR is dispensable
conserved, and REP-specific residues revealed theirfor complex formation (Supplemental Figure S1 avail-
segregated distribution (Figure 1B). The centers of theable at http://www.cell.com/cgi/content/full/117/6/
RBP and the CBR are occupied by invariant residues749/DC1). The structures of the interface between RBP
surrounded by amino acids that are conserved in theof REP-1 and Rab7 are nearly identical in prenylated and
RabGDI/REP family. The REP-specific residues are lo-unprenylated complexes and bury a surface of 1074 A˚2
cated on the edge of the Rab:REP interface, possiblycomposed of a combination of hydrophobic and charge
providing an additional anchoring for the Rab molecule.interactions (Figure 2). The most extensive contacts are
established by the invariant rabR79, which forms a net-
work of hydrogen bonds with the conserved repN225 Interaction of the C-Terminal Binding Region
of REP-1 with the C Terminus of Rab7and invariant repE379. It is noteworthy that mutations in
repE379 and repQ382 were shown to severely impair the As in RabGDI, the CBR of REP-1 is composed of apolar
residues, forming a hydrophobic cavity above the MELactivity of both the yeast REP homolog and RabGDI
(Alory and Balch, 2000; Schalk et al., 1996; Wu et al., that coordinates the C terminus of Rab7 (Rak et al.,
2003a). The CBR interaction area comprises ca. 400A˚2.1998). In addition to repE379, residue repR386 of the Rab
binding platform was shown to be critical for the function The distal traceable residues of the Rab7 C terminus,
rabP189, rabI190, and rabL192, are involved in hydrophobicof RabGDI and REP-1 (Alory and Balch, 2000; Schalk et
al., 1996). These amino acids establish the hydrogen interactions with the CBR of REP-1 (Figures 1A, 1C,
and 1F). Additionally, they are stabilized by hydrogenbonds to the conserved residues rabD44 and rabD63 of
the Switch I and Switch II regions (Figures 2 and 3D). bonding of the main chain of residues rabI190 and rabL192
with the main chain atoms of repA252 and repF254 locatedResidue D44 was identified earlier by its importance for
Rab interaction with GDI, since Rab1B bearing the D44N in the loop between helix C and -sheet e2 (Figure 1F).
Although the C terminus of Rab proteins is hypervari-mutation loses its ability to interact with GDI while re-
taining the ability to form a stable complex with REP-1 able, analysis of the last 20 amino acid reveals the pres-
ence of a cryptic and often inverted motif similar to the(Overmeyer et al., 1998). The differential effect of the
D44N mutation of Rab1B on its interaction with REP and IKL sequence of Rab7, typically containing a polar amino
acid flanked by hydrophobic residues (Figure 2D). ToRabGDI probably reflects the fundamental functional
segregation of REP and GDI in vivo. Thus, as long as test the importance of these residues for Rab prenylation
directly, we generated mutants of Rab7 bearing rabI190HREP retains enough affinity to Rab in order to present
it to RabGGTase and then deliver the protein to the or rabL192S substitutions. Using an in vitro prenylation
assay, we demonstrated that while rabI190H was onlymembrane, its function should not be affected. In the
case of the GDI molecule, whose primary biological slightly underprenylated compared to wild-type Rab7,
the prenylation of rabL192S was reduced by ca. 90%function is extraction of Rab molecules out of the mem-
Structural Basis of Rab Prenylation
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Figure 1. Structure of the Rab7:REP-1 Complex
(A) Ribbon representation of REP-1 (blue) bound to Rab7 (yellow). Domain I (dark blue), domain II (light blue), and the Rab binding platform
(RBP) (red) of REP-1 are highlighted. CBR of REP-1 is colored in dark orange and MEL in sky blue. The geranylgeranyl lipid is shown in ball-
and-stick representation. The Switch I and II regions of Rab7 are highlighted in gray and green, respectively. The dashed green line represents
part of the Switch I region of Rab7 not visible in the structure. GDP (atomic colors) and the Mg2 ion are shown in ball-and-stick and space
filling representation, respectively.
(B) Rab binding elements of REP-1. REP-1 is displayed as a gray molecular surface and the residues involved in complex formation with Rab7
are colored according to their conservation in RabGDI/REP family: blue-invariant residues, green-conserved residues, and red-the REP specific
residues. The geranylgeranyl is displayed as in (A).
(C) Interaction of the C termini of Rab7 and REP-1 with the CBR of REP-1 based of the structures of prenylated Rab7:REP-1, Rab7C22:REP-1,
and RabGGTase:REP-1 complexes. Ribbon representation of REP-1 (blue) in complex with Rab7 superimposed with the structure of REP-1
(red) in complex with RabGGTase. The N-and C termini of REP-1 in complex with RabGGTase are displayed. The dashed red line represents
the part of the C terminus of REP-1 in complex with RabGGTase that is not visible in the density map. Helix 5 and the C terminus of Rab7
are displayed in magenta. The C terminus of REP-1 molecule 2 from the Rab7C22:REP-1 complex displayed in green.
(D) C-terminal sequences of Rab and REP proteins with the hydrophobic binding motive highlighted in red.
(E) Interaction of the CBR of REP-1 in complex with REP-1 with its own C terminus. The hydrophobic patch of REP-1 is displayed in surface
representation and hydrophobic residues are colored in yellow. The main chain atoms involved in hydrogen bond formation are displayed in
Structural Basis of Rab Prenylation
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Figure 2. Schematic Representation of the Interactions between Rab7 and REP-1 at the Protein-Protein Interface
(A) Polar interactions. Hydrogen bonds are shown as dotted blue lines between the interacting groups. The water molecules are shown as
blue balls. Residues that are invariable in the RabGDI/REP family are highlighted in blue, while the conserved residues are shown in green.
The REP-1 specific residues are colored in red. Residues whose mutation negatively influences Rab interactions with RabGDI/REP family
members are marked in magenta.
(B) Hydrophobic interactions. The hydrophobic interactions are shown as gray dotted lines. The residues are colored as in (A).
(data not shown). These results suggest that fixation of dues repI611 and repL613 pointing toward the bottom of
the hydrophobic cavity in an arrangement very reminis-the Rab C terminus by the CBR is critical for prenylation
of Rab in the Rab:REP complex by RabGGTase. A plau- cent of the interactions with the C terminus of Rab7
(Figure 1E) (Pylypenko et al., 2003). In the structure ofsible interpretation of the results is that in the mutant
Rab proteins, the last 25 amino acids of the C terminus the prenylated Rab7:REP-1 complex, the C terminus of
REP-1 points toward the top of domain I and adopts aare disordered in the catalytic ternary complex (i.e.,
Rab:REP:RabGGTase) and are delocalized over a much very different conformation to that seen in the structure
of REP-1 in complex with RabGGTase (Figure 1C). Thus,larger area than in the native complex. This decreases
the probability of C-terminal cysteine association with it appears that the C terminus of REP-1 functions as a
lid covering the site that interacts with the Rab C termi-the active site of RabGGTase, resulting in reduced pre-
nylation efficiency. The CBR appears to promote prenyl- nus. The structure of the truncated Rab7:REP-1 complex
revealed two Rab7C22:REP-1 dimers per asymmetrication of Rab proteins by increasing the concentration
of their C-terminal cysteines in the vicinity of the trans- unit (Supplemental Figure S1 available on Cell website)
that are connected by the C termini of REP-1 moleculesferase active site. The fact that only one hydrophobic
residue is strictly required for efficient fixation of the C that bind to the CBRs of the neighboring REP-1 mole-
cules, supporting the notion of obligatory associationterminus explains the low degree of conservation of the
CBR interacting motif in the Rab family. of this site with either the REP or Rab C terminus (Fig-
ure 1G).It is noteworthy that in the structure of REP-1 in com-
plex with RabGGTase, the same hydrophobic cavity of Due to the great diversity in the C-terminal sequences
of Rab proteins and the opposite orientation of Rab andCBR is occupied by the C terminus of REP-1, with resi-
atomic colors. The C terminus of REP-1 form is displayed as a red worm and the residues interacting with the CBR are displayed in ball-and-
stick representation. The hydrogen bonds are displayed as strings of tiny blue balls.
(F) Interaction of the Rab7 C terminus with the CBR of REP-1 displayed and colored as in (E). The C terminus of Rab7 is displayed as a
magenta worm and the residues interacting with the hydrophobic patch are displayed in ball-and-stick format. The water molecules are
displayed as blue balls.
(G) Interaction of molecule 1 of REP-1 in complex with Rab7C22 with the C terminus of molecule 2 of REP-1 form the same complex. The
C terminus of REP-1 molecule 2 is displayed as in (E) and colored in green. Unless otherwise indicated, this and other figures were prepared
using ICM 3.0.25j (Molsoft).
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Figure 3. Conformational Changes in Rab7 upon Complex Formation and Basis for the GDI Effect
(A) Superposition of the C atoms of Rab7:GDP in complex with REP-1 (red) and apo-Rab7:GDP (green) with overall rmsd of 1.9A˚. The N-
and C-terminus of Rab7 as well as the Switch regions are labeled by arrows. The Mg2 ion is displayed as a magenta ball and the nucleotide
is displayed in ball-and-stick format in atomic colors.
(B) A stereo view of a superposition of Rab7:GDP in complex with REP-1 (red) with apo-Rab7:GppNHp (blue). Rab proteins are displayed in
worm representation while REP-1 is displayed as a gray molecular surface. The Mg2 ion and the nucleotide are displayed as in (A).
(C) Interaction of REP-1 residues (gold) with the Switch I and II regions of Rab7:GDP (gray) in worm and ball and stick representation. Water
molecules are displayed as blue balls. The Mg2 ion is presented as a magenta ball, GDP is represented in green and the interacting atoms
are presented in atomic colors. The hydrogen bonds are displayed as strings of tiny blue balls.
(D) Superposition of domain II of REP-1 (red worm) in complex with Rab7 with domain II of REP-1 (blue worm) in complex with RabGGTase
(yellow worm). Residues REPR290 and REPF279 that play a key role in binding to RabGGTase are displayed in ball-and-stick representation.
REP C termini in the identified binding area, such a Conformational Changes in the Rab7 Molecule
upon Complex Formation and the Moleculargeneric binding site is unlikely to rely on specific polar
interactions of amino acid side chains. Instead, the inter- Basis of the GDI Effect
Comparison of the apo-Rab7 molecule in the GDPactions are formed via main chain hydrogen bonds and
hydrophobic interactions of side chains with a hy- bound conformation and Rab7:REP-1 complex struc-
tures reveals structural rearrangements in the Rab7 mol-drophobic cavity. However, a hydrophobic patch on the
surface of REP would compromise the protein’s solubil- ecule upon complex formation and provides clues on
the nature of the nucleotide dissociation inhibition (GDI)ity, and this appears to be the reason why it is covered
by the C terminus of REP in the uncomplexed form. This effect and REP’s selectivity for the GDP bound form of
RabGTPases. Figure 3A depicts the structure of Rab7model finds additional support in the observation that
C-terminal deletion of yeast REP results in association in complex with REP-1 superimposed with the structure
of apo-Rab7:GDP. The overall rmsd of the C atoms isof the mutant protein with the membrane, presumably
because of its increased hydrophobicity (Miaczynska et 1.2 A˚, with the main structural differences clustered in
the Switch I and II regions. In the structure of monomerical., 1997).
Structural Basis of Rab Prenylation
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GDP:Rab7, the Switch I region is disordered between quence of rigid body movements, reflecting its structural
flexibility (Supplemental Figure S2A available on Cellresidues 34 and 43, which is typical for the GDP bound
website).form of RabGTPases (Stroupe and Brunger, 2000). In
Inspection of the REP-1 molecular surface revealsthe structure of the complex, residues 41–43 become
the presence of an unusual conical cavity in domain IIvisible in the electron density, and residue rabD44 is
(Figures 4C and 4D). It comprises a narrow tunnel thatmoved toward -helix 5 due to hydrogen bonding with
passes through the domain II and is composed of theresidues repR386 and repY251 of the Rab binding platform
residues of D, E, G, and H helices. The tunnel has theand rabD63 of  sheet 4 (Figure 3B).
largest volume in prenylated Rab7:REP-1 complex, in-Similar to the Switch I region in the structure of uncom-
termediate volume in the Rab7C22:REP-1 complexplexed GDP:Rab7, residues 64–72 of the Switch II region
and is smallest in RabGGTase:REP1 complex. It is linedare also not visible in the electron density, indicating
almost exclusively by hydrophobic residues conservedtheir high flexibility. In the complexed state, the entire
among members of the RabGDI/REP-1 family (Rak etSwitch II becomes structured and forms polar and hy-
al., 2003a). In the structure of the RabGGTase:REP-1drophobic contacts with the Rab binding platform and
complex, side chains of the residues repV271, repP272,the N terminus of REP-1 (Figures 2 and 3C).
repR275, and repV278 block the tunnel; while in theThe position and flexibility of the Switch regions influ-
Rab7:REP-1 complexes, helix D is pushed laterally fromences the affinity of GTPases for nucleotides, in particu-
domain II opening the hydrophobic core (Figure 3D; Sup-lar the rates of nucleotide release. This feature is ex-
plemental Figure S2B available on Cell website).ploited by exchange factors, such as SOS, which
Although the position, shape, and hydrophobic naturestabilizes the Switch I region of H-Ras in an open confor-
of the tunnel make it a very suitable candidate for harbor-mation, thus promoting nucleotide dissociation (Bori-
ing the conjugated geranylgeranyl group, the initial anal-ack-Sjodin et al., 1998). From this perspective, one can
ysis of the difference electron density map of the prenyl-view members of the RabGDI/REP family as factors,
ated Rab7:REP-1 complex did not reveal interpretablewhich are mechanistically analogous but functionally
density for a lipid moiety. The suggestion of a refereeopposite to the exchange factors.
prompted us to explore whether the absence of electronThe GDI effect in Rab:REP complex appears to be
density for the C terminus was the result of densityexerted by ordering of the Switch II region, whose resi-
suppression by the use of bulk solvent model duringdues form hydrogen bonds to the water molecules coor-
refinement. To address this possibility, we calculateddinating the Mg2 ion essential for the high affinity bind-
a simulated-annealing sigma-weighted composite omiting of the -and -phosphates of the guanine nucleotide
map without bulk solvent correction. This revealed addi-as well as for GTPase activity (Figure 3C). The stabiliza-
tional density located in the putative lipid binding sitetion of the water molecules coordinating the essential
and allowed modeling of the geranylgeranyl moiety (Fig-Mg2 ion provides a plausible mechanistic basis for the
ure 4B). Further model refinement revealed that the iso-ability of RabGDI/REP family members to inhibit GDP
prenoid lipid B-factor is relatively high compare to sur-exchange on Rab proteins.
rounding residues and probably reflect its generallyAs mentioned in the introduction, members of the
dynamic properties typical for protein conjugated gera-RabGDI/REP family preferentially interact with RabGT-
nylgeranyl moieties (Hoffman et al., 2000).Pases in the GDP bound conformation. Superposition
The lack of electron density for the peptide and weakof the structure of the Rab7:GppNHp complex with
density for the isoprenoid part of the tail indicates thatRab7:GDP in complex with REP-1 reveals that the
the nature of the Rab C terminus association with its
Switch regions of the former adopt conformations quite
chaperone REP might be different in detail from RabGDI
distinct from those of the REP-complexed GDP bound
and much less static than might be imagined. The differ-
form (Figure 3B). In particular, the Switch II region is ence between the structure presented in the this work
located in a plane nearly perpendicular to the same and that of the Ypt1:GDI complex, in which the lipid
region of the GDP bound form (in complex with REP-1), moiety is clearly visible even after solvent flattening, is
and this position would lead to a number of steric probably related to the differences in the detailed roles
clashes with the Rab binding platform (Figure 3B). This of REP and GDI. REP needs to have a high affinity to
provides a convincing mechanistic explanation for the unprenylated Rabs in order to promote their prenylation.
preference of RabGDI/REP family members for Rab pro- The purpose of the interaction of the prenylated C termi-
teins in the GDP bound conformation. nus with REP is to achieve solubilization of Rabs, but
not necessarily to provide affinity, which is already high
Conformational Changes in the REP-1 Molecule due to the strong interaction with the GTPase domain.
and the Location of the Isoprenoid Binding Site GDI has a low affinity to unprenylated Rabs, which in-
Comparison of the REP-1 structure complexed with creases dramatically on prenylation. Thus, it is quite
RabGGTase and with prenylated or truncated Rab7 re- conceivable that fixation of the prenylated Rab C termi-
veals structural rearrangements in domain I of REP-1. nus to REP is relatively loose. This would also be com-
It involves the structural changes described above in mensurate with its role of releasing Rabs to their target
the C terminus as well as in the first four residues of membrane, which would occur more easily than would
the N terminus that moves toward the Rab7 molecule be possible if the interaction were stronger.
making contact with the Switch II region of Rab7 (Figure Opening of the hydrophobic cavity in domain II could
1C). Domain II of REP-1 adopts different positions rela- be induced in principle by several different mechanisms.
It might occur solely a result of interaction of the gera-tive to domain I in all compared complexes as a conse-
Cell
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Figure 4. Model of the Catalytic Ternary Rab7:REP-1:RabGGTase Complex
(A) Ribbon representation of the complex. Rab7 and REP-1 are colored as in Figure 1. The proposed position of the Rab7 C terminus of the
unprenylated complex is depicted as a yellow line while the putative position of the doubly prenylated C terminus in the putative lipid binding
site on REP-1 is shown as a violet line. The  subunit of RabGGTase is colored sky blue, the  subunit of RabGGTase dark green, GGPP in
the active site of RabGGTase is displayed in ball-and-stick format (atomic colors) and Zn2 is shown as a small magenta ball.
(B) Plot of a simulated annealing sigma weighted composite omit map showing 2Fo-Fc density contoured at 0.8	 in a region of the geranylgeranyl
lipid. The helixes of the domain II and the respective side chain residues are displayed. The picture was generated with BobScript and PovRay.
(C) Lipid binding site of REP-1. Domain II of REP-1 molecule in complex with Rab in surface representation colored according to charge.
Domain I is shown in ribbon representation and the effector loop is colored in gold. The position of the lipid binding cavity is marked by an arrow.
(D) Domain II of the REP-1 molecule in complex with RabGGTase displayed as in (C).
nylgeranyl moieties conjugated to RabGTPase C termi- binding site increases, for instance, in complex with
doubly prenylated RabGTPase.nus with domain II of REP. It might also arise as a result
of a rearrangement caused by the interaction of Rab
proteins with the Rab binding platform and/or with CBR
Coevolution of the RabGDI/REP and Rabof REP. Alternatively, it could be present in the uncom-
Protein Familiesplexed REP and then occupied by lipid upon completion
RabGDI and REP proteins share several sequence con-of the prenylation reaction. Although the structures of
served regions (SCR1A, 1B, 2, 3A, and 3B) in amino-apo-REP-1 and the doubly prenylated Rab:REP com-
terminal and central regions of the proteins that wereplex would be needed to construct a complete model,
shown to play a critical role in their function (Alory andwe propose that binding of Rab GTPase to the Rab
Balch, 2001). Analysis of the Rab:REP interface revealsbinding platform of REP leads to relaxation of domain
that four of these regions overlap with structural ele-II and increases the flexibility of helix D so that it can shift
ments involved in complex formation. The largest regionoutwardly, thus providing access to the hydrophobic
of sequence conservation, SCR2, covers helixes D and Ebinding core of the molecule that can harbor isoprenoid
of domain II and the CBR on domain I of REP. Therefore,moieties. The conjugated lipid functions as a chock fix-
these elements are involved in coordination of the Rabing the helix D in its most open conformation. It is worth
C terminus and binding of the conjugated isoprenoid.noting that helices D and E in the structure of the unpre-
SCRs 3A and 3B cover the Rab binding platform, helixnylated complex remain parallel to each other in both
H, and the effector loop and thus represent structuralmolecules of the asymmetric unit while in the structure
elements involved in the binding of Rab proteins andof the prenylated Rab7:REP-1 complex helix D is tilted
their membrane delivery. The SCR1A and B appear towith respect to helix E, leading to further dilation of
be only partially involved in direct interaction with Rabthe binding site. In the recently solved structure of the
proteins. Apart form the extreme N terminus, which inter-Ypt1:GDI complex, the cavity between helix D and E
acts with the Switch II region of Rab proteins, most offilled with geranylgeranyl moiety is expanded further
than in the presented Rab7:REP-1 complex (Rak et al., SCR1 is buried in the core of domain I and comprises
its structural scaffold. These findings suggest that the2003a). This suggests that the further expulsion of helix
D and dilation of the hydrophobic cavity in the REP-1 RabGDI/REP family is defined primarily by conserved
structural elements involved in complexation of prenyl-molecule may occur when the occupancy of the lipid
Structural Basis of Rab Prenylation
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ated RabGTPases that have been conserved throughout complex, residues repF279 and repR290 located on helices
D and E play key roles in formation of a binding interfacethe evolution of eukaryotic organisms.
Global analysis of the Rab protein family from various and their interaction with the  subunit is critical for the
activity of the catalytic complex (Pylypenko et al., 2003;organisms has led to the identification of five conserved
sequence motifs termed RabFs that define the Rab fam- Alory and Balch, 2000). Thus, we are now in a position
to propose a sequence of events occurring during andily (Pereira-Leal and Seabra, 2000). From analysis of the
Rab7 regions involved in the interaction with REP-1, it after the prenylation reaction. We propose that upon
prenylation, the conjugated geranylgeranyl moieties arecan be seen that the binding interfaces on Switches I
and II overlap with RabF motifs 1, 2, 3, and 4. The RabF5 expelled from the active site on the RabGGTase by bind-
ing of a further GGPP molecule, as shown previouslymotif is not part of the interface but is part of the core
of the GTPase molecule not exposed to the surface. (Thoma et al., 2001), and migrate on its surface until they
reach domain II of the REP molecule. The isoprenoidMoreover, it has notable homology with the same region
of Ral-b and Rap1a and therefore appears to represent invades the hydrophobic core of domain II, leading on
the one hand to dilation of a lipid-harboring hydrophobica part of the structural scaffold of small GTPases with
some family specific variations. cavity through separation of helixes D and E and on the
other to displacement of repF279 (Helix D) and repR290The described findings shed light onto the long-stand-
ing question concerning the identity of the Ypt/Rab pro- (Helix E) from their binding sites on RabGGTase. This
decreases the affinity of RabGGTase for the REP:Rabtein family. It appears that four sequence motifs con-
served throughout the Rab family represent the interaction complex and leads to product release by the enzyme.
interface with generic regulators from the RabGDI/REP
family, while the fifth motif is part of a molecular scaffold. REP Homologs and the Molecular Basis
The rest of the molecule appears to be much less con- of Choroideremia Disease
served, which is not at all surprising considering the As indicated in the introduction, mutations in the REP-1
hundreds of protein:protein interactions and the large gene can lead to progressive retinal degradation, which
number of pathways Rab proteins engage in. Thus, the has been proposed to be due to the inability of the
RabGTPase family can be defined by the ability of its REP-2 gene product to efficiently complement the loss
members to be prenylated exclusively by RabGGTase of the REP-1 gene (Pereira-Leal et al., 2001). Sequence
and be shuffled between the membranes and the cytosol comparison of REP-1 and REP-2 demonstrates that
by RabGDI. Comparison of the 11 RabGTPases from the among residues involved in Rab binding, only the A252V
yeast genome with over 60 family members identified in and Y365F substitutions can be identified. The first sub-
the human genome demonstrates that the family has stitution is not expected to influence the interaction
coevolved with its key regulators, preserving both the since only the main chain oxygen is involved in formation
structure of the protein:protein interface and the func- of a hydrogen bond with rabL192 via a water molecule. In
tional mechanism. At the same time, other regions of contrast, Y365F substitution could potentially influence
the molecule have diversified and evolved to respond the interaction between the molecules, since this resi-
to the ever-increasing complexity of the intracellular ve- due is located on the effector loop and its substitution
sicular transport machinery. This appears to be an ex- could change the coordination of the C terminus of the
ample of the evolutionary clock ticking with a different Rab protein. However, REP-1 Y365F and REP-2 F370Y
rhythm on opposite sides of a single protein domain. mutants interacted with the Rab7 with affinities nearly
identical to those of the wild-type proteins and the rates
of Rab prenylation remained unaffected as determinedStructure of the Catalytic Ternary Complex and
the Mechanism of Product Release by equilibrium titration measurements and in vitro
prenylation (data not shown).The availability of the RabGGTase:REP-1 and REP-1:
Rab7 structures enables us to model the structure of In order to investigate functional differences between
REP homologs, we developed a system allowing realthe catalytic ternary complex. A superposition of REP-1
in complex with RabGGTase and Rab7, respectively, is time monitoring of Rab prenylation. Using an expressed
protein ligation technique, we constructed a Rab27Ashown in Figure 4A. In the resulting model, the Rab
molecule is located above the  subunit of RabGGTase molecule with a fluorescent NBD group integrated be-
tween the two prenylatable cysteines (Figure 5A). Whenand the last visible residue of the C terminus is posi-
tioned ca. 35 A˚ above its active site. This distance can the fluorescent sensor was incubated with RabGGTase
and REP proteins in the presence of GGPP, a time-be easily bridged by the disordered portion of the Rab7
C terminus, thus providing a plausible model for the dependent fluorescence increase was observed (Figure
5B). This increase reflected the genuine prenylation re-structure of the ternary complex. The lipid binding site
on REP-1 is located ca. 30 A˚ from the RabGGTase active action, as confirmed by its susceptibility to a specific
competitive inhibitor of RabGGTase as well as by masssite, potentially presenting a significant obstacle for the
prenylated C terminus to overcome in docking to this spectroscopy analysis of the product (data not shown).
This assay allowed us to directly monitor the rates ofbinding site. This is in accord with biochemical data that
demonstrate that product release by RabGGTase is very Rab27A prenylation by RabGGTase and test the influ-
ence of REP homologs on this process. We observedslow and strongly stimulated by the presence of deter-
gents, which are expected to facilitate the mobility of that the rates of prenylation mediated by REP-1 and
REP-2 differ only by ca. 2-fold. A similar difference inconjugated isoprenoids in an aqueous environment (An-
dres et al., 1993; Thoma et al., 2001). prenylation rates was observed when we analyzed pre-
nylation of Rab7 in the presence of REP-1 or REP-2It was previously shown that in the RabGGTase:REP
Cell
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Figure 5. Construction of Fluorescent Rab27A and Analysis of Interaction of REP-1 and REP-2 with Rab Proteins
(A) Construction scheme of semisynthetic fluorescent Rab27A protein and its application in in vitro prenylation.
(B) In vitro prenylation of Rab27-CK(NBD)C with RabGGTase in the presence of REP-1 or REP-2. The data were fitted to single exponentials
resulting in kobs 
 0.02 s1 for REP-1 and kobs 
 0.01 s1 for REP-2. Increase in concentration of the enzyme by 5-fold did not result in increase
of either observed rates or amplitudes.
(C and D) Fluorescence titration of dans_Rab7 (C) and dans_Rab27A with REP-2 (D). The concentrations of dansylated Rab7 and Rab27A
were 250 nM. Data fitting led to Kd values of ca. 5 and 800 nM in (A) and (B), respectively.
(E) In vitro prenylation of 200 nM of semisynthetic Rab27A-CK(NBD)C protein with 250 nM RabGGTase and REP-2. Black line, fluorescence
signal change in the absence of competitor; green line, fluorescence change in the presence of 600 nM of wild-type Rab27A; red line,
fluorescence change in the presence of 200 nM of wild-type Rab7.
(data not shown). Therefore, the underprenylation of affinity of Rab27 for both isoforms of REP makes it more
sensitive to a reduction in overall REP activity. Thus, ifRab27A in choroideremia cannot be explained by inabil-
the total activity REP becomes limiting, the low affinityity of REP-2 to support prenylation of Rab27A. It was
of Rab27 will not allow it to compete favorably with othersuggested earlier that Rab27A might have a lower affin-
Rabs for prenylation. To test this hypothesis directly,ity for REP-2 compared to REP-1 (Cremers et al., 1994).
we performed Rab27A prenylation experiments as de-In order to address this issue directly, we used an estab-
scribed above in the presence of various concentrationslished fluorescence titration assay (Alexandrov et al.,
of either wild-type Rab27A or Rab7 as a competitor. As2001) to determine the affinity of several Rab proteins,
can be seen in Figure 5E, while a 3-fold excess ofincluding Rab1A, Rab7, and Rab27A, for REP-1 and -2.
Rab27A only partially reduced the rate and absoluteWe found that the affinities of Rab GTPases for REP
amount of prenylated Rab27A-CK(NBD)C, the presencemolecules vary by more then two orders of magnitude
of equimolar amounts of Rab7 completely inhibitedand that REP-1 bound stronger than REP-2 to all Rab
the reaction.proteins tested (Table 2). However, there does not ap-
The structural basis for the affinity difference of REPpear to be a specific effect on Rab27A. We also experi-
protein interaction with different Rab proteins is difficultmentally established that the affinities of Rab7 and
to gauge based on the available data. With the exceptionRab27A in complex with REP-1 and -2 for RabGGTase
of Q67, Q71, S72, S111, L192, and I190, all residues onwere close to 100 nM and did not vary significantly
the Rab:REP interface are invariant in all three Rabs(Supplemental Figure S5 available on Cell website).
tested (Supplemental Figure S4 available on Cell web-Therefore, it is more probable that the generally lower
site). The variant residues are involved primarily in hy-
drogen bond formation via their main chain atoms or
involved in hydrophobic interactions via their conservedTable 2. Dissociation Constants Determined for the Interaction of
REP Isoforms with Rab Proteins side chains. The salient feature of Rab27A is a 10-resi-
due insertion in loop 3. However, sequence alignmentProteins Rab7 Rab1A Rab27A
and homology modeling suggest that this insertion is
REP-1 0.8  0.5 nM 43  17 nM 200  22 nM located on the side of the molecule opposite to Rab:REP
REP-2 5.0  1.4 nM 118  12 nM 811  35 nM
interface and thus unlikely to have a direct influence on
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body refinement, where domain I (residues 3–264 and 370–606) andcomplex affinity. Given the large size of the Rab:REP
domain II (residues from 265–369) were considered as two rigidinterface and cooperative nature of interactions among
bodies, and positional refinement using a slow-cooling protocolindividual residues, the overall affinity is likely to result
improved the initial model. The calculated phases gave clear elec-
from a sum of numerous factors influenced by the geom- tron density for most of the residues of Rab7 molecule, allowing
etry and flexibility of the individual proteins leading to model building. Iterative cycles of manual rebuilding using O (Jones
et al., 1991) followed by slow-cooling minimization and B-factora broad variation in complex affinities. The diversity of
refinement in CNS continued until the Rfree converged. An annealedaffinities probably reflects the need of Rab proteins to
sigma weighted composite omit-map without bulk solvent correc-interact not only with RabGDI/REP family members but
tion revealed additional density in the putative lipid binding sitealso with other more specific regulatory and effector
that was modeled as geranylgeranyl moiety and included in the
molecules whose binding sites might be in the vicinity final model.
or in some case even shared with those of GDI and The prenylated Rab7:GDP:REP-1 structure excluding the C-ter-
minal part of Rab7, GDP, Mg2 ion, and geranylgeranyl was usedREP (Day et al., 1998). Since mutations of switch region
as a search model for the Rab7C22:GDP:REP-1 molecular replace-residues not directly involved in Rab:REP complex for-
ment solution. Two dimers of the Rab7C22GDP-Rep-1 complexmation were shown to dramatically influence the stability
were found in the asymmetric unit. Structure refinement was carriedof the complex, such an explanation appears quite plau-
out as described above with strict noncrystallographic symmetry
sible (Wilson and Maltese, 1993; Overmeyer et al., 1998). (NCS) between the dimers enforced at the initial cycles. In the final
The obtained data allow us to propose a model for refinement cycles, the four molecules were refined without NCS.
The Rab7C22GDP and Rab7:GppNHp structures were solvedthe accumulation of undeprenylated Rab27 in the cells
by molecular replacement with the Rab7 structure (excludingof choroideremia patients. Loss of the REP-1 gene re-
C-terminal, Switch I and II regions, and GDP) from prenylatedduces the amount of total REP activity and shifts all
Rab7:GDP:REP-1 as a search model. The models were refined usingprenylation to the REP-2 protein. A high Kd (i.e., low the described above procedure.
affinity) of the Rab27:REP-2 interaction in combination
with active synthesis of other Rab proteins in retinal cells
Assays for Rab Interaction with REP-1 and 2, Constructionresults in competition among Rab proteins for remaining
of Semisynthetic Fluorescent Rab27-CK(NBD)CREP molecules and disfavors molecules with low affin-
Molecules, and In Vitro Prenylation Assaysity. From this perspective, choroideremia and Herman-
Wild-type recombinant Rab1A, Rab7, and Rab27A were C-terminally
sky-Pudlak syndrome appear to be closely related dis- modified with dansyl or rhodamine groups and their interactions
eases involving Rab underprenylation in which the exact with REP-1 and -2 or with RabGGTase were monitored using a
set of the most affected GTPases is determined by rela- fluorescent titration assay as described using direct titrations
(Rab1A, Rab7) or a combination of direct and competitive titrationstive affinities between RabGGTase components and
(Alexandrov et al., 1999, 2001). For construction of fluorescent pre-Rab proteins as well as by the relative concentrations
nylatable protein, Rab27A was C-terminally truncated by threeof the latter. This suggests that increasing REP-2 levels
amino acids and fused with an intein domain as implemented in the
might be sufficient to alleviate choroideremia symp- pTWIN-2 vector (NEB). The fusion protein was expressed, purified,
toms. This could be achieved, in principle, by a gene cleaved, and a tripeptide (Cys-Lys(NBD)-Cys) mimicking the missing
therapeutic approach, or perhaps via stabilization of C terminus was ligated onto the thioester-tagged Rab27A essentially
as described (Iakovenko et al., 2000). Fluorescence spectra andREP-2 mRNA by designed chemical entities.
long time base fluorescence measurements were performed with
an Aminco SLM 8100 spectrophotometer (Aminco). All reactionsExperimental Procedures
were followed at 25C in 25 mM HEPES [pH 7.2], 40 mM NaCl, 2 mM
MgCl2, 2 mM DTE, and 10 M GDP in 1 ml volume. FluorescenceProtein Expression and Purification, Complex Formation
of NBD-labeled Rab27 was excited at 470 nm and data were col-Expression and purification of RabGGTase, REP-1, REP-2, Rab7
lected at 540 nm. For in vitro prenylation experiments, the concentra-wild-type and Rab7C22 was performed as described elsewhere
tions of fluorescent Rab27 protein was kept at 200 nM while the(Alexandrov et al., 1999; Kalinin et al., 2001; Sidorovitch et al., 2002).
subunits of RabGGTase were added to a concentration of 250 nM.Genes coding for human Rab1A and Rab27A were subcloned into
In vitro prenylation of rabI190H or rabL192S mutants was performedpGATEV and pET19-tev vectors, respectively, and protein expres-
using a novel fluorescent in vitro prenylation assay that will be de-sion and purification was performed as described above. Point mu-
scribed elsewhere (B. Dursina, R. Reents, M. Thutewohl, A. Kalinin,tations in Rab7, REP-1, and REP-2 genes were generated with the
V. Evstifeev, D. Ciobanu, S.E. Szedlacsek, H. Waldmann, R.S.G.,QuickChange mutagenesis kit (Stratagene) and proteins were ex-
and K.A., unpublished data).pressed and purified as described above. The GppNHp bound form
of wild-type Rab7 was prepared essentially as described for the
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